Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Lisata Therapeutics (LSTA) over the last 11 years, with Q3 2025 value amounting to $1000.0.

  • Lisata Therapeutics' Change in Receivables changed N/A to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $502000.0, marking a year-over-year increase of 65651.63%. This contributed to the annual value of $900000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Lisata Therapeutics reported Change in Receivables of $1000.0 as of Q3 2025.
  • In the past 5 years, Lisata Therapeutics' Change in Receivables ranged from a high of $900000.0 in Q4 2024 and a low of -$249000.0 during Q2 2025